126 related articles for article (PubMed ID: 17037004)
1. The depot of buprenorphine decanoate produced a dose-related long-lasting antinociceptive effect in guinea pigs.
Wu SZ; Liu KS; Chu KS; Cheng KI; Kuei CH; Wang JJ; Tzeng JI
Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):161-8. PubMed ID: 17037004
[TBL] [Abstract][Full Text] [Related]
2. Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effect.
Liu KS; Tzeng JI; Chen YW; Huang KL; Kuei CH; Wang JJ
Anesth Analg; 2006 May; 102(5):1445-51. PubMed ID: 16632824
[TBL] [Abstract][Full Text] [Related]
3. A novel long-acting analgesic: buprenorphine palmitate in rats.
Que J; Lin LC; Liu SY; Chu CC; Liu KS; Ho ST; Wang JJ
Acta Anaesthesiol Taiwan; 2005 Mar; 43(1):11-6. PubMed ID: 15868999
[TBL] [Abstract][Full Text] [Related]
4. Novel depots of buprenorphine have a long-acting effect for the management of physical dependence to morphine.
Liu KS; Kao CH; Liu SY; Sung KC; Kuei CH; Wang JJ
J Pharm Pharmacol; 2006 Mar; 58(3):337-44. PubMed ID: 16536900
[TBL] [Abstract][Full Text] [Related]
5. The antinociceptive and anti-inflammatory effects of a long-acting depot formulated ketorolac in rats.
Tzeng JI; Chu CC; Feng PH; Hou CH; Shieh JP; Ho ST; Wang JJ
Acta Anaesthesiol Taiwan; 2005 Mar; 43(1):17-22. PubMed ID: 15869000
[TBL] [Abstract][Full Text] [Related]
6. The antinociceptive effect of buprenorphine and its long-acting ester buprenorphine benzoate in rats.
Yang C; Lan KM; Liu KS; Chen YW; Tzeng JI; Ho ST; Wang JJ
Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):135-9. PubMed ID: 15551890
[TBL] [Abstract][Full Text] [Related]
7. The antinociceptive effect of a long-acting nalbuphine preparation in rabbits.
Ho ST; Wang JJ; Hu OY; Tzeng JI; Liu KS; Chen YW
Acta Anaesthesiol Sin; 2003 Sep; 41(3):99-103. PubMed ID: 14601195
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
9. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
Yu G; Yue YJ; Cui MX; Gong ZH
J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of a novel long-acting nalbuphine preparation.
Liu KS; Hu OY; Ho ST; Tzeng JI; Chen YW; Wang JJ
Br J Anaesth; 2004 May; 92(5):712-5. PubMed ID: 15003978
[TBL] [Abstract][Full Text] [Related]
11. Dose-related antinociceptive effects of intravenous buprenorphine in cats.
Steagall PV; Mantovani FB; Taylor PM; Dixon MJ; Luna SP
Vet J; 2009 Nov; 182(2):203-9. PubMed ID: 18691917
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive efficacy of buprenorphine administered through the drinking water of rats.
Jessen L; Christensen S; Bjerrum OJ
Lab Anim; 2007 Apr; 41(2):185-96. PubMed ID: 17430618
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive and anti-inflammatory effects of five depot formulations of ketorolac propyl ester in rats.
Wang LK; Wang PJ; Hou CH; Chu CC; Tzeng JI; Shieh JP; Wang JJ
Acta Anaesthesiol Taiwan; 2005 Jun; 43(2):85-92. PubMed ID: 16060403
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of butorphanol, buprenorphine, or both, administered intramuscularly in cats.
Johnson JA; Robertson SA; Pypendop BH
Am J Vet Res; 2007 Jul; 68(7):699-703. PubMed ID: 17605603
[TBL] [Abstract][Full Text] [Related]
16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
Cichewicz DL; Welch SP; Smith FL
Eur J Pharmacol; 2005 Nov; 525(1-3):74-82. PubMed ID: 16288738
[TBL] [Abstract][Full Text] [Related]
18. Influence of preferred foodstuffs on the antinociceptive effects of orally administered buprenorphine in laboratory rats.
Leach MC; Forrester AR; Flecknell PA
Lab Anim; 2010 Jan; 44(1):54-8. PubMed ID: 19858164
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of buprenorphine in healthy, lactating goats.
Ingvast-Larsson C; Svartberg K; Hydbring-Sandberg E; Bondesson U; Olsson K
J Vet Pharmacol Ther; 2007 Jun; 30(3):249-56. PubMed ID: 17472657
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of thermal antinociceptive effects after intramuscular administration of buprenorphine hydrochloride to American kestrels (Falco sparverius).
Ceulemans SM; Guzman DS; Olsen GH; Beaufrère H; Paul-Murphy JR
Am J Vet Res; 2014 Aug; 75(8):705-10. PubMed ID: 25061700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
